RISA Labs Inc的动态

Can Artificial Intelligence (AI) help treat cancer? A lab in Vancouver, WA, believes that in the very near future AI will lead to cancer breakthroughs by quickly pinpointing the exact treatment needed for each person’s cancer. This could greatly speed up the treatment process and make it more effective. Bernard A. Fox PhD who leads our Molecular and Tumor Immunology Laboratory weighed in on the potential of using AI to treat cancer. At first skeptical, he’s now an advocate. Hear what Dr. Fox says about this potential game-changing approach to treating cancer: https://lnkd.in/gQtX7i3K.

Can Artificial Intelligence (AI) help treat cancer? A lab in Vancouver, WA, believes that in the very near future AI will lead to cancer breakthroughs by quickly pinpointing the exact treatment needed for each person’s cancer. This could greatly speed up the treatment process and make it more effective. Bernard A. Fox PhD who leads our Molecular and Tumor Immunology Laboratory weighed in on the potential of using AI to treat cancer. At first skeptical, he’s now an advocate. Hear what Dr. Fox says about this potential game-changing approach to treating cancer: https://lnkd.in/gQtX7i3K.

Lung cancer remains a significant health concern, ranking as the third most common cancer in the UK and a leading cause of mortality. Almost half (45.5%) of all cancer cases were diagnosed at stages 3 and 4 (out of those with a known stage at diagnosis) in England. Check out the video for a look at how Epsom & St Helier NHS Trust in Southwest London is using Annalise's AI solution for early cancer detection. #digitalhealth #transformativeai

Machine learning models must be transparent and interpretable, identify and mitigate bias and be robust and secure, all while maintaining high performance. https://lnkd.in/eShXbzyP

??TECH WATCH: Check out what TEAM TATRC is reading about this week in the news!?? "What if there were a way to test — quickly and accurately — all the potential paths forward? That’s the goal of digital twins. An artificial intelligence (AI)–based program uses all the known data on a patient and their type of illness and creates a “twin” that can be used over and over to simulate disease progression, test treatments, and predict individual responses to therapies. “What the [digital twin] model can do for the clinician is to hold all that information and process it really quickly, within a couple of minutes,” Asghar noted." Follow the link for more!

Lung cancer remains a significant health concern, ranking as the third most common cancer in the UK and a leading cause of mortality. Almost half (45.5%) of all cancer cases were diagnosed at stages 3 and 4 (out of those with a known stage at diagnosis) in England. Check out the video for a look at how Epsom & St Helier NHS Trust in Southwest London is using Annalise's AI solution for early cancer detection. #digitalhealth #transformativeai

With #AI anyone is able to uplift the value they get out of a day by reducing time and energy spent on mundane tasks to give more space to focus on impact. And #Copilot simply is THE one and only UI for AI. #UIforAI #UI4AI #MakeMoreImpact #msftadvocate

Big news! Lunit and Rezolut have launched SecondReadAI, an innovative AI-powered tool that provides a second opinion on mammograms. It helps spot subtle details that could be missed and boosts early-stage cancer detection by up to 15%! Patients can opt-in easily when booking their next mammogram, with no extra imaging or appointment time needed. And with flexible payment options, it’s never been easier to access advanced cancer detection when it matters most. https://lnkd.in/gtrWrpet

TEVOGEN BIO to Develop Predictive T Cell Technology with Microsoft The most recent collaboration will allow Teva to use the power of Microsoft’s AI technology to build on its successes to date and use machine learning to quickly and accurately identify new treatment targets.

The real value of AI... Saving lives...